| Warfarin pharmacogenomics in diverse populations JB Kaye, LE Schultz, HE Steiner, RA Kittles, LH Cavallari, JH Karnes Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (9 …, 2017 | 106 | 2017 |
| Comparison of HLA allelic imputation programs JH Karnes, CM Shaffer, L Bastarache, S Gaudieri, AM Glazer, HE Steiner, ... PloS one 12 (2), e0172444, 2017 | 71 | 2017 |
| Psychological and genetic predictors of pain tolerance AE Patanwala, C Norwood, H Steiner, D Morrison, M Li, K Walsh, ... Clinical and translational science 12 (2), 189-195, 2019 | 23 | 2019 |
| Racial, ethnic, and gender differences in obesity and body fat distribution: An All of Us Research Program demonstration project JH Karnes, A Arora, J Feng, HE Steiner, L Sulieman, E Boerwinkle, ... PloS one 16 (8), e0255583, 2021 | 21 | 2021 |
| Genetic admixture and survival in diverse populations with pulmonary arterial hypertension JH Karnes, HW Wiener, TH Schwantes-An, B Natarajan, AJ Sweatt, ... American journal of respiratory and critical care medicine 201 (11), 1407-1415, 2020 | 21 | 2020 |
| Influence of human leukocyte antigen (HLA) alleles and killer cell immunoglobulin‐like receptors (KIR) types on heparin‐induced thrombocytopenia (HIT) JH Karnes, CM Shaffer, R Cronin, L Bastarache, S Gaudieri, I James, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (9 …, 2017 | 16 | 2017 |
| Machine learning for prediction of stable warfarin dose in US Latinos and Latin Americans HE Steiner, JB Giles, HK Patterson, J Feng, N El Rouby, K Claudio, ... Frontiers in Pharmacology 12, 749786, 2021 | 12 | 2021 |
| ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia JH Karnes, J Rollin, JB Giles, KL Martinez, HE Steiner, CM Shaffer, ... Blood, The Journal of the American Society of Hematology 140 (3), 274-284, 2022 | 9 | 2022 |
| Efficacy of personal pharmacogenomic testing as an educational tool in the pharmacy curriculum: A nonblinded, randomized controlled trial C Grace, MM Larriva, HE Steiner, S Marupuru, PJ Campbell, H Patterson, ... Clinical and Translational Science 14 (6), 2532-2543, 2021 | 8 | 2021 |
| Multi‐site investigation of genetic determinants of warfarin dose variability in Latinos N El Rouby, L Rodrigues Marcatto, K Claudio, L Camargo Tavares, ... Clinical and translational science 14 (1), 268-276, 2021 | 8 | 2021 |
| Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia JB Giles, HE Steiner, J Rollin, CM Shaffer, Y Momozawa, T Mushiroda, ... Blood Advances 6 (14), 4137-4146, 2022 | 7 | 2022 |
| Role of the gut microbiome in cardiovascular drug response: The potential for clinical application HE Steiner, K Gee, J Giles, H Knight, BL Hurwitz, JH Karnes Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 42 (2 …, 2022 | 6 | 2022 |
| Bringing pharmacomicrobiomics to the clinic through well‐designed studies HE Steiner, HK Patterson, JB Giles, JH Karnes Clinical and Translational Science 15 (10), 2303-2315, 2022 | 3 | 2022 |
| Elucidation of cellular contributions to heparin-induced thrombocytopenia using Omic approaches JB Giles, EC Miller, HE Steiner, JH Karnes Frontiers in Pharmacology 12, 812830, 2022 | 3 | 2022 |
| Local Ancestry‐Informed Candidate Pathway Analysis of Warfarin Stable Dose in Latino Populations HE Steiner, KC Carrion, JB Giles, AR Lima, K Yee, X Sun, LH Cavallari, ... Clinical Pharmacology & Therapeutics 113 (3), 680-691, 2023 | | 2023 |
| Appendix A-Bringing Pharmacomicrobiomics to the Clinic Through Well-Designed Studies HE Steiner, HK Patterson, JB Giles, JH Karnes Increasing Inclusion of Participants, Leveraging Gut Microbiomes, and …, 2022 | | 2022 |
| Appendix E-Vitamin K Antagonist Pharmacomicrobiomics-A Study Protocol and Feasibility Test HE Steiner, K Blumberg, M Miller, X Sun, H Patterson, K Yee, G Watts, ... Increasing Inclusion of Participants, Leveraging Gut Microbiomes, and …, 2022 | | 2022 |
| Appendix C-Machine Learning for Prediction of Stable Warfarin Dose in US Latinos and Latin Americans HE Steiner, JB Giles, HK Patterson, J Feng, N El Rouby, K Claudio, ... Increasing Inclusion of Participants, Leveraging Gut Microbiomes, and …, 2022 | | 2022 |
| Increasing Inclusion of Participants, Leveraging Gut Microbiomes, and Optimizing Machine Learning Models to Advance Warfarin Precision Medicine HE Steiner The University of Arizona, 2022 | | 2022 |
